14,474 results found

The newly-enacted Bipartisan Budget Act of 2018 includes numerous Medicare, Medicaid, and other policy and payment provisions impacting health providers and manufacturers.

In the February 9, 2016, Federal Register, USDA's APHIS issued an interim rule amending regulations pertaining to certain diseases of livestock and poultry to specify conditions for payment of indemnity claims for HPAI.

In the August 12, 2016, Federal Register, USDA's APHIS issued a final rule amending the NPIP, its auxiliary provisions, and the indemnity regulations for the control of H5 and H7 low pathogenic avian influenza.

The comment period extension will allow interested persons additional time to submit comments.

In addition, APHIS proposes to revise the bovine tuberculosis- and brucellosis-related import requirements for cattle and bison to make these requirements clearer and ensure that they more effectively mitigate the risk of introduction of these diseases into the United States.

. APHIS also proposed to revise its regulation regarding the movement of plant pests and soil, and proposed criteria regarding the movement and environmental release of biological control organisms.

Additionally, avocados from Colombia would be required to be accompanied by a phytosanitary certificate with an additional declaration stating that the avocados have been produced in accordance with the proposed requirements.

Accordingly, APHIS is reopening the comment period for an additional 30 days to give interested parties additional time to review the pathway-initiative risk assessment.

In the February 27, 2015, Federal Register, USDA's APHIS announced the solicitation of public comments regarding the list of select agents and toxins that have the potential to pose a severe threat to animal or plant health...

Recently, Biogen and Samsung Bioepis's ranibizumab biosimilar (BYOOVIZ) was granted interchangeable status by the U.S. Food and Drug Administration. BYOOVIZ was deemed interchangeable...

On November 16, 2017, California's three cannabis licensing authorities announced proposed emergency licensing regulations for medicinal and adult-use commercial cannabis businesses.

A bill to add warning labels to sugar-sweetened drinks passed the California state Senate last month, but the state Assembly's Health Committee rejected it.

Although the Massachusetts Cannabis Control Commission has begun awarding provisional, adult-use licenses to some entities in the Commonwealth as of July 1, only one retail license has been awarded...

Duane Morris partners Seth Goldberg and David Feldman, members of Duane Morris' Cannabis Law Practice Group, were panelists for an ACG webinar, "Cannabis: Investing in One of the Fastest "Growing"...

In the April 29, 2015, Federal Register, FDA's Center for Devices and Radiological Health issued a progress update on its 2014–2015 Strategic Priority titled "Strike the Right Balance Between Premarket and Postmarket Data Collection."

The program aims to provide CDRH staff with a better understanding of devices they review through discussions with industry leaders.

On April 14, 2025, Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to YUFLYMA (adalimumab-aaty)...

Celltrion USA announced on March 18, 2024, the availability of ZYMFENTRA™ (infliximab-dyyb), a subcutaneous (SC) formulation of infliximab.